Immune status characteristics in patients with hormonal disorders and undifferentiated connective tissue dysplasia

<b>Immune status characteristics in patients with hormonal disorders and undifferentiated connective tissue dysplasia<br> </b><br> I.Yu. Ilina, Yu.E. Dobrokhotova, A.A. Chikisheva, V.O. Malikova<br> Pirogov Russian National Research Medical University, Moscow, Russia...

Full description

Bibliographic Details
Main Author: Chikisheva A.A.
Format: Article
Language:Russian
Published: LCC «Medicine-Inform» 2019-06-01
Series:РМЖ. Мать и дитя
Online Access:http://wchjournal.com/upload/iblock/e3d/e3d79a79067e4f610c472c8b372c0ef7.pdf
_version_ 1797294951340441600
author Chikisheva A.A.
author_facet Chikisheva A.A.
author_sort Chikisheva A.A.
collection DOAJ
description <b>Immune status characteristics in patients with hormonal disorders and undifferentiated connective tissue dysplasia<br> </b><br> I.Yu. Ilina, Yu.E. Dobrokhotova, A.A. Chikisheva, V.O. Malikova<br> Pirogov Russian National Research Medical University, Moscow, Russian Federation<br> <br> In recent decades, many papers on connective tissue dysplasia (CTD) were published. High occurrence, multiple organ lesion, and unfavorable (quite often) outcomes of this disorder account for its medical social importance.<br> Structural and functional alterations resulted from CTD progression occur in various organs and tissues. They are accompanied by immune disorders, cellular, phagocytic, and humoral immune response deficiency.<br> <b>Aim</b>: to assess the effect of enzyme therapy on immune alterations in reproductive age women with undifferentiated connective tissue dysplasia.<br> <b>Patients and Methods:</b> 212 women of reproductive age with clinical manifestations of hyperandrogenism and infertility were enrolled in the study. Group I included 84 women with CTD signs (39.6%), group II included 128 women without CTD (60.4%). Both groups were subdivided into the subgroups depending on the hormonal abnormalities. IgA, IgG, IgM, IgЕ, circulating immune complexes, and C3 and C4 complement proteins were measured. Both groups received systemic treatment, Wobenzym (5 tablets 3 times a day for a month, then 3 tablets 3 times a day for 2 months).<br> <b>Results</b>: the occurence of hyperandrogenism of various nature in women with and without CTD is almost similar. In women with CTD the occurence of genital prolapse is higher than in women with normal collagen metabolism. IgE levels in women with CTD are 1.5-times higher than in women without CTD. Moreover, these abnormalities were more severe in women with hormonal imbalance.<br> <b>Conclusion</b>: women of reproductive age with CTD require metabolic therapy to normalize collagen synthesis in combination with systemic enzyme therapy since they are characterized by increased collagen breakdown. Some changes in immune parameters typical for connective tissue disorders may be revealed.<br> <br> <b>Key words: </b>immune status, connective tissue dysplasia, immunoglobulins, circulating immune complexes, systemic enzyme therapy.<br> <b>For citation: </b>Ilina I.Yu., Dobrokhotova Yu.E., Chikisheva A.A., Malikova V.O. Immune status characteristics in patients with hormonal disorders and undifferentiated connective tissue dysplasia. Russian Journal of Woman and Child Health. 2019;2(1):23–27.<br>
first_indexed 2024-03-07T21:39:03Z
format Article
id doaj.art-f392b2768d064a7da4c192455ca2a2f0
institution Directory Open Access Journal
issn 2618-8430
2686-7184
language Russian
last_indexed 2024-03-07T21:39:03Z
publishDate 2019-06-01
publisher LCC «Medicine-Inform»
record_format Article
series РМЖ. Мать и дитя
spelling doaj.art-f392b2768d064a7da4c192455ca2a2f02024-02-26T10:13:32ZrusLCC «Medicine-Inform»РМЖ. Мать и дитя2618-84302686-71842019-06-012132924Immune status characteristics in patients with hormonal disorders and undifferentiated connective tissue dysplasia0Chikisheva A.A.1Russian Journal of Woman and Child Health, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Woman and Child Health, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399<b>Immune status characteristics in patients with hormonal disorders and undifferentiated connective tissue dysplasia<br> </b><br> I.Yu. Ilina, Yu.E. Dobrokhotova, A.A. Chikisheva, V.O. Malikova<br> Pirogov Russian National Research Medical University, Moscow, Russian Federation<br> <br> In recent decades, many papers on connective tissue dysplasia (CTD) were published. High occurrence, multiple organ lesion, and unfavorable (quite often) outcomes of this disorder account for its medical social importance.<br> Structural and functional alterations resulted from CTD progression occur in various organs and tissues. They are accompanied by immune disorders, cellular, phagocytic, and humoral immune response deficiency.<br> <b>Aim</b>: to assess the effect of enzyme therapy on immune alterations in reproductive age women with undifferentiated connective tissue dysplasia.<br> <b>Patients and Methods:</b> 212 women of reproductive age with clinical manifestations of hyperandrogenism and infertility were enrolled in the study. Group I included 84 women with CTD signs (39.6%), group II included 128 women without CTD (60.4%). Both groups were subdivided into the subgroups depending on the hormonal abnormalities. IgA, IgG, IgM, IgЕ, circulating immune complexes, and C3 and C4 complement proteins were measured. Both groups received systemic treatment, Wobenzym (5 tablets 3 times a day for a month, then 3 tablets 3 times a day for 2 months).<br> <b>Results</b>: the occurence of hyperandrogenism of various nature in women with and without CTD is almost similar. In women with CTD the occurence of genital prolapse is higher than in women with normal collagen metabolism. IgE levels in women with CTD are 1.5-times higher than in women without CTD. Moreover, these abnormalities were more severe in women with hormonal imbalance.<br> <b>Conclusion</b>: women of reproductive age with CTD require metabolic therapy to normalize collagen synthesis in combination with systemic enzyme therapy since they are characterized by increased collagen breakdown. Some changes in immune parameters typical for connective tissue disorders may be revealed.<br> <br> <b>Key words: </b>immune status, connective tissue dysplasia, immunoglobulins, circulating immune complexes, systemic enzyme therapy.<br> <b>For citation: </b>Ilina I.Yu., Dobrokhotova Yu.E., Chikisheva A.A., Malikova V.O. Immune status characteristics in patients with hormonal disorders and undifferentiated connective tissue dysplasia. Russian Journal of Woman and Child Health. 2019;2(1):23–27.<br>http://wchjournal.com/upload/iblock/e3d/e3d79a79067e4f610c472c8b372c0ef7.pdf
spellingShingle Chikisheva A.A.
Immune status characteristics in patients with hormonal disorders and undifferentiated connective tissue dysplasia
РМЖ. Мать и дитя
title Immune status characteristics in patients with hormonal disorders and undifferentiated connective tissue dysplasia
title_full Immune status characteristics in patients with hormonal disorders and undifferentiated connective tissue dysplasia
title_fullStr Immune status characteristics in patients with hormonal disorders and undifferentiated connective tissue dysplasia
title_full_unstemmed Immune status characteristics in patients with hormonal disorders and undifferentiated connective tissue dysplasia
title_short Immune status characteristics in patients with hormonal disorders and undifferentiated connective tissue dysplasia
title_sort immune status characteristics in patients with hormonal disorders and undifferentiated connective tissue dysplasia
url http://wchjournal.com/upload/iblock/e3d/e3d79a79067e4f610c472c8b372c0ef7.pdf
work_keys_str_mv AT chikishevaaa immunestatuscharacteristicsinpatientswithhormonaldisordersandundifferentiatedconnectivetissuedysplasia